LONDON, June 16 /PRNewswire/ --

- Fifth International Conference on Rare Earths, Hong Kong 17-19 November 2009

There have been some radical changes in the rare earth industry over the last twelve months. In the short term, the downturn in the global economy has led to the price of key rare earth oxides such as neodymium falling by more than 50%, as well as temporary plant closures.

SINGAPORE, June 16 /PRNewswire/ --

- New Mobile Broadband Satellite Service Delivers Fastest On-Demand Video Streaming Anywhere, Anytime

Inmarsat, the leading provider of mobile satellite communications services, today announced the launch of BGAN X-Stream in the Asia Pacific region, completing the global coverage for the new service. BGAN X-Stream offers broadcasters access to the world's fastest on-demand video streaming via satellite. The service was unveiled at CommunicAsia 2009 in Singapore, which attracts leading broadcast and telecommunications professionals from around the world.

CUPERTINO, California, June 16 /PRNewswire/ --

- Campaign on Play's WAP Portal Bears First Fruit of Strategic Global Alliance Between Mobixell and OgilvyOne

SANTA CLARA, California, June 16 /PRNewswire/ --

SAI Technology Inc. (SAI), a leading developer of advanced wireless and security technology solutions, announced it has introduced the world's first complete end-to-end LTE (Long Term Evolution) software protocol stack (PDCP, RLC, RRC, MAC PHY-MAC API's) and system infrastructure software that is openly available to customers and development partners.

Most LTE solutions today have been developed for in-house captive products, said Dr. Venkat Rayapati (CEO, SAI Technology Inc.). SAI has been a pioneer in the development of 4G wireless solutions. The launch of our new LTE software protocol stack builds on the strength of our earlier successful launch of the fixed and mobile WiMAX system technology products.

BOSTON, June 16 /PRNewswire/ --

- Pitavastatin Represents Important Treatment Option for More Vulnerable Populations

New data presented today showed that pitavastatin is an effective treatment for the management of dyslipidaemia in elderly patients, with a similar safety and tolerability profile to low-dose pravastatin. The Phase III data were presented today by Kowa, at the XV International Symposium on Atherosclerosis in Boston.

EVANSTON, Illinois, June 16 /PRNewswire/ --

- Increasing power of public health care payers drives need for significantly revamped sales models in Europe -

Despite rampant downsizing in the pharmaceutical industry, pharmaceutical companies in Europe cannot rely solely on sales force reductions to drive future success. Instead, they must break with tradition and change how they sell to Europe's increasingly powerful public health care payers.

These are among the conclusions of a new report by global management consulting firm ZS Associates and eyeforpharma, a leading provider of pharmaceutical business intelligence and conferences.

PORTON DOWN, England, June 16 /PRNewswire/ --

Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today it was issued European Patent EP1044283, which covers the use of endonuclease-based reporting in PCR and other nucleic acid amplification technologies. Becton, Dickinson and Company (BD) had filed a claim in opposition to this patent which was rejected by the European Patent Office at a proceeding in Munich on May 28.

DUBLIN, June 16 /PRNewswire/ --

- New Facility Part of Ambitious Expansion Plans at Central Manchester University Hospitals Foundation Trust Campus

ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has signed a collaborative agreement with the Central Manchester University Hospitals Foundation (CMFT) to develop a purpose built translational medicine facility.

ROCKVILLE, Maryland and INDIANAPOLIS, June 16 /PRNewswire/ --

- Phase 3 PROTEGE ENCORE Clinical Trial Initiated

MacroGenics, Inc. and Eli Lilly and Company (NYSE: LLY) today announced that the PROTEGE trial achieved its targeted patient enrollment. The trial is a pivotal Phase 2/3 clinical study evaluating teplizumab, an investigational compound under development for the treatment of individuals with recent-onset type 1 diabetes.

HIGH WYCOMBE, England, June 16 /PRNewswire/ -- APMG-International (APMG) announces the release of a Qualification for Service Catalogue. The qualification initiated by market leaders newScale, headquartered in San Francisco and Pink Elephant in Toronto, Canada, has been developed over the last several months and is the second complimentary qualification for the ITIL(R) Qualification Portfolio.

The Service Catalogue qualification was subject to independent review and scrutiny by the International Qualifications Committee of itSMF International, the leading Service Management movement with 52 different Chapters.